...
首页> 外文期刊>European Journal of Cancer Supplements >497 Combination therapy with an Aurora B kinase inhibitor {AZD1152} and AraC, shows enhanced tumouricidal activity in a preclinical model of acute myeloid leukaemia (AML)
【24h】

497 Combination therapy with an Aurora B kinase inhibitor {AZD1152} and AraC, shows enhanced tumouricidal activity in a preclinical model of acute myeloid leukaemia (AML)

机译:497与Aurora B激酶抑制剂{AZD1152 }和AraC的联合治疗在急性髓样白血病(AML)的临床前模型中显示出增强的杀肿瘤活性

获取原文
           

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号